Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Class A Common Stock, par value $0.01
Shares outstanding
313,041,907
Total 13F shares
101,691,059
Share change
+3,242,253
Total reported value
$484,034,077
Put/Call ratio
52%
Price per share
$4.76
Number of holders
131
Value change
+$16,566,905
Number of buys
62
Number of sells
68

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Fosun International Ltd
13F
Company
6.9%
21,521,301
$74,893,000 31 Mar 2020
13F
TPG Group Holdings (SBS) Advisors, Inc.
13F
Company
5.2%
16,213,367
$56,423,000 31 Mar 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
4.9%
15,323,849
$53,325,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
3.4%
10,741,404
$37,381,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
3%
9,299,973
$32,363,000 31 Mar 2020
13F
Neuberger Berman Group LLC
13F
Company
1.2%
3,830,086
$13,303,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
0.77%
2,417,142
$8,412,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.55%
1,706,562
$5,938,000 31 Mar 2020
13F
NORTHERN TRUST CORP
13F
Company
0.5%
1,554,407
$5,409,000 31 Mar 2020
13F
FEDERATED HERMES, INC.
13F
Company
0.47%
1,464,659
$5,097,000 31 Mar 2020
13F
Bank of New York Mellon Corp
13F
Company
0.4%
1,253,008
$4,360,000 31 Mar 2020
13F
NORGES BANK
13F
Company
0.36%
1,127,504
$3,924,000 31 Mar 2020
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.31%
976,119
$3,397,000 31 Mar 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.23%
706,806
$2,460,000 31 Mar 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.17%
543,569
$1,891,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.16%
515,787
$1,795,000 31 Mar 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.16%
500,280
$1,741,000 31 Mar 2020
13F
LSV ASSET MANAGEMENT
13F
Company
0.11%
355,800
$1,238,000 31 Mar 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.11%
351,576
$1,224,000 31 Mar 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.1%
310,149
$1,079,000 31 Mar 2020
13F
CREDIT SUISSE AG/
13F
Company
0.09%
268,505
$935,000 31 Mar 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.09%
268,260
$934,000 31 Mar 2020
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.08%
247,774
$862,000 31 Mar 2020
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.08%
236,760
$824,000 31 Mar 2020
13F
Invesco Ltd.
13F
Company
0.07%
229,724
$800,000 31 Mar 2020
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.07%
219,728
$765,000 31 Mar 2020
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.07%
216,842
$755,000 31 Mar 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.07%
214,326
$746,000 31 Mar 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.07%
213,549
$743,000 31 Mar 2020
13F
Russell Investments Group, Ltd.
13F
Company
0.07%
208,396
$724,000 31 Mar 2020
13F
Swiss National Bank
13F
Company
0.07%
208,100
$724,000 31 Mar 2020
13F
FIRST TRUST ADVISORS LP
13F
Company
0.07%
205,485
$715,000 31 Mar 2020
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.06%
199,263
$693,000 31 Mar 2020
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.06%
190,184
$662,000 31 Mar 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.06%
182,500
$635,000 31 Mar 2020
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.06%
182,291
$634,000 31 Mar 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.06%
179,688
$625,000 31 Mar 2020
13F
MACKENZIE FINANCIAL CORP
13F
Company
0.06%
177,878
$619,000 31 Mar 2020
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.05%
167,514
$583,000 31 Mar 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
155,006
$539,000 31 Mar 2020
13F
Spark Investment Management LLC
13F
Company
0.04%
136,658
$475,000 31 Mar 2020
13F
STRS OHIO
13F
Company
0.04%
136,500
$475,000 31 Mar 2020
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.04%
131,860
$459,000 31 Mar 2020
13F
Engineers Gate Manager LP
13F
Company
0.04%
127,564
$444,000 31 Mar 2020
13F
BARCLAYS PLC
13F
Company
0.04%
123,976
$431,000 31 Mar 2020
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.04%
118,340
$413,000 31 Mar 2020
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.04%
116,728
$406,213 31 Mar 2020
13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC
13F
Company
0.04%
111,896
$390,000 31 Mar 2020
13F
SYSTEMATIC FINANCIAL MANAGEMENT LP
13F
Company
0.04%
110,580
$385,000 31 Mar 2020
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.03%
106,783
$372,000 31 Mar 2020
13F

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2020

As of 30 Jun 2020, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 101,691,059 shares. The largest 10 holders included Fosun International Ltd, TPG Group Holdings (SBS) Advisors, Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Neuberger Berman Group LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP. This page lists 131 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
117
Q2 2020 holders
131
Holder diff
14
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.